Finzati - Logo
ZYXIQ logo

Zynex, Inc.

ZYXIQ • Medical - Distribution
Extraordinary move
ZYXIQ+140.38%
vs. previous close $0.05
$0.13
▲ +0.07 (+140.38%)
Current price
EarningsLatest report: Sep 30, 2025
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$3.79M
Growth
-4.6%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Positive revenue growth · 29.4%Positive free cash flow · 0.38Consistent free cash flow · 4/5Healthy liquidity · 4.46Expensive earnings multiple · 85.45
Financial data as of: Sep 30, 2025, 12:00 AM UTCLast earnings update: Nov 17, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.13
Change140.38%
Shares Out30.31M
Market Cap$3.79M
Enterprise Value$54.30M
52W Range0.02 - 0.77
Beta1.08
P/E-0.05
P/S0.04
P/B-0.09
P/FCF-0.18
EV/Sales0.50

Investment DNA

How strong this company looks for long-term investors

57
out of 100
Business Quality
Margins, moat, returns
27/100
Financial Strength
Debt, cash, stability
59/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Positive revenue growth · 29.4%Positive free cash flow · 0.38Consistent free cash flow · 4/5Healthy liquidity · 4.46Expensive earnings multiple · 85.45High debt level · 2.07

Analyst view

Analyst sentiment and price target

ZYXI
Analyst sentiment
Based on 9 analyst votes · 2026-09-05
83/100
Bullish
Bullish
6
Hold
3
Bearish
0
Price Target
2026-06-06
Low
$11.00
Mean
$14.38
Median
$14.25
High
$18.00

Company Overview

IPO: 2/25/2004
Industry: Medical - Distribution
P/B i: -0.09
Debt / Equity i: 2.07
Operating Margin: 3.11%
Net Margin: 1.56%
ROE i: -
ROIC: -

Financial Health

Score12 / 20
Debt / Equity: 2.07
Current Ratio: 4.46
Quick Ratio: 3.63
Status: Good

Warnings

  • High debt level

Insider Transactions

Recent executive and insider activity

Cress Michael D
Transaction: 03/26/2026
SELL
Change
-82,501
Price
Not reported
Filing
03/27/2026
Type
SELL
Cress Michael D
Transaction: 03/26/2026
SELL
Change
-12,499
Price
Not reported
Filing
03/27/2026
Type
SELL
Disbrow Joshua R.
Transaction: 03/26/2026
SELL
Change
-89,501
Price
Not reported
Filing
03/27/2026
Type
SELL